GB1476624A - Tranquiliser medicaments - Google Patents
Tranquiliser medicamentsInfo
- Publication number
- GB1476624A GB1476624A GB2575073A GB2575073A GB1476624A GB 1476624 A GB1476624 A GB 1476624A GB 2575073 A GB2575073 A GB 2575073A GB 2575073 A GB2575073 A GB 2575073A GB 1476624 A GB1476624 A GB 1476624A
- Authority
- GB
- United Kingdom
- Prior art keywords
- antioxidant
- tranquiliser
- medicaments
- ester
- methyl arachidonate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000003814 drug Substances 0.000 title abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- 239000003963 antioxidant agent Substances 0.000 abstract 2
- 230000003078 antioxidant effect Effects 0.000 abstract 2
- 235000006708 antioxidants Nutrition 0.000 abstract 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 abstract 2
- OFIDNKMQBYGNIW-UHFFFAOYSA-N arachidonic acid methyl ester Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)OC OFIDNKMQBYGNIW-UHFFFAOYSA-N 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract 2
- OFIDNKMQBYGNIW-ZKWNWVNESA-N methyl arachidonate Chemical group CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC OFIDNKMQBYGNIW-ZKWNWVNESA-N 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- 108010024636 Glutathione Proteins 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 230000000049 anti-anxiety effect Effects 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 239000002249 anxiolytic agent Substances 0.000 abstract 1
- 229940114079 arachidonic acid Drugs 0.000 abstract 1
- 235000021342 arachidonic acid Nutrition 0.000 abstract 1
- 230000005284 excitation Effects 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003180 glutathione Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/03—Monocarboxylic acids
- C07C57/12—Straight chain carboxylic acids containing eighteen carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2575073A GB1476624A (en) | 1973-05-30 | 1973-05-30 | Tranquiliser medicaments |
| FR7417692A FR2231379B1 (enExample) | 1973-05-30 | 1974-05-21 | |
| DE19742425988 DE2425988A1 (de) | 1973-05-30 | 1974-05-30 | Medikament zur bekaempfung von erregungsund angstsyndromen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2575073A GB1476624A (en) | 1973-05-30 | 1973-05-30 | Tranquiliser medicaments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1476624A true GB1476624A (en) | 1977-06-16 |
Family
ID=10232682
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2575073A Expired GB1476624A (en) | 1973-05-30 | 1973-05-30 | Tranquiliser medicaments |
Country Status (3)
| Country | Link |
|---|---|
| DE (1) | DE2425988A1 (enExample) |
| FR (1) | FR2231379B1 (enExample) |
| GB (1) | GB1476624A (enExample) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2831507A1 (de) * | 1978-05-26 | 1979-11-29 | Wellcome Found | (alle-z)-5,8,11,14,17-eicosapentaensaeure und/oder deren derivate enthaltende formulierungen, sowie verfahren zu ihrer herstellung |
| EP0087865B1 (en) * | 1982-03-01 | 1986-10-01 | Efamol Limited | Pharmaceutical composition |
| AU663923B2 (en) * | 1992-04-08 | 1995-10-26 | Transcend Therapeutics, Inc | Method and composition for treating immune disorders, inflammation and chronic infections |
| WO2005107875A3 (en) * | 2004-05-12 | 2006-03-23 | Ketocytonyx Inc | Triglycerides, fatty acids, alcohols as cns modulators |
| US7485743B2 (en) | 2004-07-20 | 2009-02-03 | Btg International Limited | Oligomeric ketone compounds |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ205076A (en) * | 1982-08-09 | 1985-04-30 | Univ California | Protecting and healing gastro-duodenal mucosa and the liver of mammals using a fatty acid |
| EP0106571A3 (en) * | 1982-09-22 | 1984-07-25 | Sentrachem Limited | Prophylactic substance or composition |
| GB8302708D0 (en) * | 1983-02-01 | 1983-03-02 | Efamol Ltd | Pharmaceutical and dietary composition |
| FR2548021B1 (fr) * | 1983-06-29 | 1986-02-28 | Dick P R | Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels |
| GB8319073D0 (en) * | 1983-07-14 | 1983-08-17 | Efamol Ltd | Fatty acid compositions |
| CA1239587A (en) * | 1983-10-24 | 1988-07-26 | David Rubin | Combined fatty acid composition for lowering blood cholestrol and triglyceride levels |
| FR2573653B1 (fr) * | 1984-11-23 | 1988-02-26 | Pf Medicament | Compositions pharmaceutiques antiandrogenes a base d'acides gras |
| FR2581310B1 (fr) * | 1985-05-02 | 1988-09-23 | Natura Medica Laboratoires | Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose |
| DE3615710A1 (de) * | 1986-05-09 | 1987-11-26 | Hoechst Ag | Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen |
| DE3719097C1 (de) * | 1987-06-06 | 1988-06-09 | Fratzer Uwe | Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E |
-
1973
- 1973-05-30 GB GB2575073A patent/GB1476624A/en not_active Expired
-
1974
- 1974-05-21 FR FR7417692A patent/FR2231379B1/fr not_active Expired
- 1974-05-30 DE DE19742425988 patent/DE2425988A1/de not_active Withdrawn
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2831507A1 (de) * | 1978-05-26 | 1979-11-29 | Wellcome Found | (alle-z)-5,8,11,14,17-eicosapentaensaeure und/oder deren derivate enthaltende formulierungen, sowie verfahren zu ihrer herstellung |
| EP0087865B1 (en) * | 1982-03-01 | 1986-10-01 | Efamol Limited | Pharmaceutical composition |
| AU663923B2 (en) * | 1992-04-08 | 1995-10-26 | Transcend Therapeutics, Inc | Method and composition for treating immune disorders, inflammation and chronic infections |
| WO2005107875A3 (en) * | 2004-05-12 | 2006-03-23 | Ketocytonyx Inc | Triglycerides, fatty acids, alcohols as cns modulators |
| US7485743B2 (en) | 2004-07-20 | 2009-02-03 | Btg International Limited | Oligomeric ketone compounds |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2231379A1 (enExample) | 1974-12-27 |
| FR2231379B1 (enExample) | 1977-12-23 |
| DE2425988A1 (de) | 1974-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1476624A (en) | Tranquiliser medicaments | |
| ATE56358T1 (de) | Chlorfluorkohlenstoff-treibstoffaerosolpr|parate, die arzneimittel enthalten. | |
| DE3669103D1 (de) | Ibuprofen enthaltendes arzneimittel. | |
| GR3001312T3 (en) | Pharmaceutical composition containing 2-(2-fluoro-4-biphenylyl)propionic acid or a salt thereof | |
| YU45346B (en) | Process for obtaining pharmaceutical active 1-substituted oxindole-3-carboxamide | |
| FR2393580A1 (fr) | Systeme de conservation du sang | |
| DE3579128D1 (de) | 13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel. | |
| ES2051678T1 (es) | Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos. | |
| MY104412A (en) | Acne treatment. | |
| FR2381521A1 (fr) | Base pour des preparations medicamenteuses a usage externe, preparation medicamenteuses preparees a l'aide de celle-ci et procede pour leur preparation | |
| ES2090712T3 (es) | Medicamento agudo que contiene ibuprofeno y su uso. | |
| BG50375A3 (en) | Gelatine capsule | |
| IE39671L (en) | Medicament containing a higher alkanol | |
| GR3002513T3 (en) | Use of glycofurol in liquefying pharmaceutical preparations for filling soft gelatin capsules | |
| ES2090703T3 (es) | Medicamento agudo que contiene flurbiprofeno y su empleo. | |
| DK159323C (da) | Oestrioldiestere samt farmaceutiske praeparater indeholdende disse | |
| GB1195200A (en) | Pharmaceutical Compositions. | |
| ATE110570T1 (de) | Nephroprotektive infusionslösung. | |
| GB1435685A (en) | Hydroxyl-subst | |
| AU3080092A (en) | Slow-release ibuprofen-containing medicament and its use | |
| GB1387803A (en) | Watersoluble salts of polyhydroxyphenylchromanones | |
| NL7903434A (nl) | Derivaten van benzoylfenoxyalkaancarbonzuren met anti- lipemische en anticholesterolemische werking, alsmede farmaceutische preparaten die zo'n verbinding bevatten. | |
| Emmelot et al. | Fatty acid oxidation in malignant and normal livers. IV. The mechanism of the stimulatory effect of some alpha-oxy-acids on fatty acid oxidation in cellfree tissue preparations of normal livers | |
| GB1530251A (en) | Esters of 6,11-dihydrodibenzo-(b.e.)-thiepin-11-one-3-alkanoic acids and processes for making same | |
| GB1391900A (en) | 3-benzylpyrido-3,4-e-astriazine and 1,2-dihydro-3-benzylpyrido- 3,4-e-as-triazine hydrochloride |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |